Skip to main content

Table 1 Clinical characteristics and neuropathy measures of groups 1 and 2

From: Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy

Group Group 1 (n = 21) Group 2 (n = 32) p value
Age 57.4 ± 9.1 55.7 ± 7.6 0.46
Sex (male/female) 13/8 20 /12 0.77
Body mass index (kg/m2) 30.1 ± 6.0 31 ± 5.6 0.55
HbA1c (%) 8.7 ± 1.6 7.8 ± 1.4 0.04*
Cholesterol (mmol/L) 5.7 ± 1.4 5.9 ± 1.1 0.56
Triglyceride (mmol/L) 2.8 ± 1.8 2.8 ± 2.5 0.96
Diabetes duration (years) 8.6 ± 6.9 9.9 ± 6.2 0.50
MFD, baseline (fibers/mm2) 3783.2 ± 1714.9 3073.7 ± 1567.3 0.14
MFD, 52 weeks (fibers/mm2) 3771.1 ± 1965.9 2942.4 ± 1750.2 0.13
MFD, change (fibers/mm2) −12.1 ± 1062.2 −131.3 ± 1082.1 0.69
ALCAR treated, n (%) 15 (71.4%) 20 (62.5%) 0.56
  1. Values are the mean ± standard deviation (SD). p value was calculated by Student’s t test and Fisher’s exact test
  2. ALCAR acetyl-L-carnitine, MFD myelinated fiber density
  3. *p value < 0.05